[Therapy of catarrhal tonsillitis in infancy with o-hydroxybenzamide (salicylamide) associated with sodium p-aminobenzoate].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D000700:Analgesics; D006801:Humans; D012457:Salicylamides; D012459:Salicylates; D012964:Sodium; D014069:Tonsillitis / Q000628:therapy*; D062366:para-Aminobenzoates
D000700:Analgesics; D012457:Salicylamides; D012459:Salicylates; D062366:para-Aminobenzoates; D012964:Sodium; C031060:salicylamide; D010129:4-Aminobenzoic Acid
PARA-AMINOBENZOIC ACID/therapeutic use; SALICYLIC ACID/derivatives; TONSILLITIS/therapy
Sulla terapia delle tonsilliti catarrali dell'infanzia con la associazione o-ossibenzamide-p-aminobenzoato sodico (salicilamide).